Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-16

Clinical Trial Update: Prostaglandin Inhibition for Emphysema [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on prostaglandin inhibition for emphysema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nebraska | Conditions: Emphysema | Phase 2 | Status: COMPLETED | Results posted: 2019-12-16